Hypothesis: ATAC-seq studies have established chromatin erosion as the central epigenetic change in the aging brain. However, I suspect the cognitive decline that follows isn't simply a direct consequence of this loss. Instead, I think neurons mount a maladaptive response—what I'd call compensatory over-consolidation of the remaining accessible chromatin regions. The brain's predictive coding machinery seems to lock onto a diminishing set of stable regulatory elements, essentially doubling down on what's left even as the foundation crumbles. This creates a systems-level pathology where a gain-of-function processaggravates the primary erosion.

Mechanistic Framework: Over a lifetime, DNA double-strand break repair leaves behind "scars" that progressively disrupt epigenetic architecture 1. Rather than establishing stable consolidated states, this introduces transcriptional noise. My hypothesis is that neurons interpret this noise as prediction error and react by ramping up HDAC2-mediated repression at memory-related gene promoters 2. The irony is striking: the most stable chromatin regions get frozen into irreversible configurations. This actually explains why HDAC inhibitors can partially reverse cognitive decline—they address both problems simultaneously: global accessibility loss and the inappropriate consolidation of residual stable elements.

The therapeutic window this model predicts differs from what the erosion-only framework suggests. Early-stage aging shows mainly erosion with some compensatory consolidation that might even be adaptive. Late-stage aging, though, crosses into pathological over-consolidation that actively suppresses whatever plasticity remains—even when accessibility could theoretically be restored.

Testable Predictions: (1) ATAC-seq of aged neurons should reveal not just accessibility loss but a bimodal pattern—extreme loss at vulnerable regions alongside aberrant persistence at previously stable enhancers; (2) RNA-seq should capture downregulated synaptic genes (from erosion) alongside suppressed immediate-early gene responses to novelty (from consolidation); (3) HDAC inhibitor treatment should differentially restore genes in these two categories, with novelty-response recovery predicting cognitive improvement; (4) Aged mice exposed to controlled uncertainty—novel environments, stochastic reward schedules—should show reduced HDAC2 occupancy at plasticity genes without worsening epigenetic noise metrics, suggesting behavioral intervention can selectively modulate the consolidation component.

This synthesis reconciles the apparent contradiction between over-consolidation theory and erosion evidence—both mechanisms are real, operating on different timescales with distinct therapeutic implications.